Ahmer Hameed1, Tony Pang1, Judy Chiou2, Henry Pleass1, Vincent Lam1, Michael Hollands1, Emma Johnston3, Arthur Richardson1, Lawrence Yuen4. 1. Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney, Australia. 2. Department of Medicine, Westmead Hospital, Sydney, Australia. 3. Department of Surgery, Westmead Hospital, Sydney, Australia. 4. Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney, Australia. Electronic address: lawrence.yuen@sydney.edu.au.
Abstract
BACKGROUND: The strategy for preoperative management of biliary obstruction in hilar cholangiocarcinoma (HCCA) patients with regards to drainage by endoscopic (EBD) or percutaneous (PTBD) methods is not clearly defined. The aim of this study was to investigate the utility, complications and therapeutic efficacy of these methods in HCCA patients, with a secondary aim to assess the use of portal vein embolization (PVE) in patients undergoing drainage. METHODS: Studies incorporating HCCA patients undergoing biliary drainage prior to curative resection were included (EMBASE and Medline databases). Analyses included baseline drainage data, procedure-related complications and efficacy, post-operative parameters, and meta-analyses where applicable. RESULTS: Fifteen studies were included, with EBD performed in 536 patients (52%). Unilateral drainage of the future liver remnant was undertaken in 94% of patients. There was a trend towards higher procedure conversion (RR 7.36, p = 0.07) and cholangitis (RR 3.36, p = 0.15) rates in the EBD group. Where specified, 134 (30%) drained patients had PVE, in association with a major hepatectomy in 131 patients (98%). Post-operative hepatic failure occurred in 22 (11%) of EBD patients compared to 56 (13%) of PTBD patients, whilst median 1-year survival in these groups was 91% and 73%, respectively. DISCUSSION: The accepted practice is for most jaundiced HCCA patients to have preoperative drainage of the future liver remnant. EBD may be associated with more immediate procedure-related complications, although it is certainly not inferior compared to PTBD in the long term. Crown
BACKGROUND: The strategy for preoperative management of biliary obstruction in hilar cholangiocarcinoma (HCCA) patients with regards to drainage by endoscopic (EBD) or percutaneous (PTBD) methods is not clearly defined. The aim of this study was to investigate the utility, complications and therapeutic efficacy of these methods in HCCA patients, with a secondary aim to assess the use of portal vein embolization (PVE) in patients undergoing drainage. METHODS: Studies incorporating HCCA patients undergoing biliary drainage prior to curative resection were included (EMBASE and Medline databases). Analyses included baseline drainage data, procedure-related complications and efficacy, post-operative parameters, and meta-analyses where applicable. RESULTS: Fifteen studies were included, with EBD performed in 536 patients (52%). Unilateral drainage of the future liver remnant was undertaken in 94% of patients. There was a trend towards higher procedure conversion (RR 7.36, p = 0.07) and cholangitis (RR 3.36, p = 0.15) rates in the EBD group. Where specified, 134 (30%) drained patients had PVE, in association with a major hepatectomy in 131 patients (98%). Post-operative hepatic failure occurred in 22 (11%) of EBD patients compared to 56 (13%) of PTBD patients, whilst median 1-year survival in these groups was 91% and 73%, respectively. DISCUSSION: The accepted practice is for most jaundiced HCCApatients to have preoperative drainage of the future liver remnant. EBD may be associated with more immediate procedure-related complications, although it is certainly not inferior compared to PTBD in the long term. Crown
Authors: W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart Journal: Ann Surg Date: 2001-10 Impact factor: 12.969
Authors: Q Lina Hu; Jason B Liu; Ryan J Ellis; Jessica Y Liu; Anthony D Yang; Michael I D'Angelica; Clifford Y Ko; Ryan P Merkow Journal: HPB (Oxford) Date: 2019-07-23 Impact factor: 3.647
Authors: B Joseph Elmunzer; Zachary L Smith; Paul Tarnasky; Andrew Y Wang; Patrick Yachimski; Filip Banovac; Jonathan M Buscaglia; James Buxbaum; Amitabh Chak; Bradford Chong; Gregory A Coté; Peter V Draganov; Kulwinder Dua; Valerie Durkalski; Brian S Geller; Laith H Jamil; Rajesh N Keswani; Mouen A Khashab; Ryan Law; Simon K Lo; Sean McCarthy; J Bayne Selby; Vikesh K Singh; Jason R Taylor; Field F Willingham; Rebecca L Spitzer; Lydia D Foster Journal: Clin Gastroenterol Hepatol Date: 2020-05-23 Impact factor: 11.382
Authors: Firas Al-Kawas; Harry Aslanian; John Baillie; Filip Banovac; Jonathan M Buscaglia; James Buxbaum; Amitabh Chak; Bradford Chong; Gregory A Coté; Peter V Draganov; Kulwinder Dua; Valerie Durkalski; B Joseph Elmunzer; Lydia D Foster; Timothy B Gardner; Brian S Geller; Priya Jamidar; Laith H Jamil; Rajesh N Keswani; Mouen A Khashab; Gabriel D Lang; Ryan Law; David Lichtenstein; Simon K Lo; Sean McCarthy; Silvio Melo; Daniel Mullady; Jose Nieto; J Bayne Selby; Vikesh K Singh; Rebecca L Spitzer; Brian Strife; Paul Tarnaksy; Jason R Taylor; Jeffrey Tokar; Andrew Y Wang; April Williams; Field Willingham; Patrick Yachimski Journal: Trials Date: 2018-02-14 Impact factor: 2.279
Authors: Eva Braunwarth; Stefan Stättner; Margot Fodor; Benno Cardini; Thomas Resch; Rupert Oberhuber; Daniel Putzer; Reto Bale; Manuel Maglione; Christian Margreiter; Stefan Schneeberger; Dietmar Öfner; Florian Primavesi Journal: Eur Surg Date: 2018-05-17 Impact factor: 0.953
Authors: Anna Tavakkoli; B Joseph Elmunzer; Akbar K Waljee; Caitlin C Murphy; Sandi L Pruitt; Hong Zhu; Rong Rong; Richard S Kwon; James M Scheiman; Joel H Rubenstein; Amit G Singal Journal: Gastrointest Endosc Date: 2020-06-09 Impact factor: 9.427